Cost-effectiveness of a community pharmacist intervention in patients with depression: a randomized controlled trial (PRODEFAR Study).
<h4>Background</h4>Non-adherence to antidepressants generates higher costs for the treatment of depression. Little is known about the cost-effectiveness of pharmacist's interventions aimed at improving adherence to antidepressants. The study aimed to evaluate the cost-effectiveness...
Guardado en:
Autores principales: | Maria Rubio-Valera, Judith Bosmans, Ana Fernández, Maite Peñarrubia-María, Marian March, Pere Travé, Juan A Bellón, Antoni Serrano-Blanco |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/04485262b957421ebe4b6a54bcf9331e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Interventions performed by clinical pharmacist in the renal transplant ambulatory care
por: Diego Gnatta, et al.
Publicado: (2020) -
Economic impact of pharmacists' interventions in asthma management: a systematic review
por: Gabriel R. FREITAS, et al.
Publicado: (2021) -
A pragmatic randomized waitlist-controlled effectiveness and cost-effectiveness trial of digital interventions for depression and anxiety
por: Derek Richards, et al.
Publicado: (2020) -
Positive evidence for clinical pharmacist interventions during interdisciplinary rounding at a psychiatric hospital
por: Matej Stuhec, et al.
Publicado: (2021) -
Interventions performed by community pharmacists in one Canadian province: a cross-sectional study
por: Young SW, et al.
Publicado: (2012)